Pronađeno: 1-10 / 17 radova

Autori: Reusch Michael

>> Filter: Samo Article i Review

>> Sve godine

  • 1
  • 2
Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article)
Autori Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. 40 br. 4, str. 1546-1559
Projekat Astellas Pharma, Inc.; Astellas Pharma, Inc. [DOLOMITES: NCT02021318]; FibroGen, Inc. [SIERRAS: NCT02273726, HIMALAYAS: NCT02052310]; AstraZeneca [ROCKIES: NCT02174731]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents in Patients with Anemia of Non-dialysis-Dependent or Incident-to-Dialysis Chronic Kidney Disease: Pooled Analysis of Four Phase 3 Studies (Article; Early Access)
Autori Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Young James Dimkovic Nada B Reusch Michael 
Info ADVANCES IN THERAPY, (2023), vol. br. , str. -
Projekat Astellas Pharma, Inc. (DOLOMITES); FibroGen, Inc.; AstraZeneca; [NCT02021318]; [NCT02273726]; [NCT02052310]; [NCT02174731]
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati:
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cardiovascular Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients With Chronic Kidney Disease Incident to or Not Receiving Dialysis: Pooled Subgroup Analysis of Four Phase 3 Studies (Meeting Abstract)
Autori Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B 
Info SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 23S-24S
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Iron Parameters in Patients Treated With Roxadustat for Anemia Associated With Chronic Kidney Disease: Post Hoc Analysis of the Non-Dialysis-Dependent or Incident Dialysis Population From Four Phase 3 Studies (Meeting Abstract)
Autori Esposito Ciro Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Jiletcovici Alina Dimkovic Nada B 
Info SWISS MEDICAL WEEKLY, (2022), vol. 152 br. , Suppl. 266, str. 14S-14S
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Safety of Roxadustat Versus Erythropoiesis-Stimulating Agents for Treatment of Anemia in Patients with Chronic Kidney Disease Incident to Or Not Receiving Dialysis: Pooled Analysis of Four Phase 3 Studies (Meeting Abstract)
Autori Barratt Jonathan Dellanna Frank Portoles Jose Choukroun Gabriel De Nicola Luca Reusch Michael Young James Dimkovic Nada B 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2022), vol. 37 br. , Suppl. 3, str. I387-I388
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: A Phase 3, randomised, open-label, active-controlled study (DOLOMITES) (vol 36, pg 1616, 2021) (Correction)
Autori Barratt Jonathan Andric Branislav R Tataradze Avtandil Schomig Michael Reusch Michael Valluri Udaya Mariat Christophe 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2022), vol. 37 br. 4, str. 805-805
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Pooled efficacy and cardiovascular safety results of roxadustat compared with placebo/ darbepoetin alfa for treatment of anaemia in patients with non-dialysis-dependent (NDD) chronic kidney disease (CKD) (Meeting Abstract)
Autori Barratt Jonathan Dimkovic Nada B Shutov Evgeny Sulowicz Wladyslaw Esposito Ciro Reusch Michael Young James Mariat Christophe 
Info SWISS MEDICAL WEEKLY, (2021), vol. 151 br. , Suppl. 256, str. 25S-25S
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Cardiovascular outcomes associated with achieved haemoglobin level and preliminary rate of rise of haemoglobin in pooled phase 3 studies of roxadustat in non-dialysis-dependent patients with anaemia (Meeting Abstract)
Autori Barratt Jonathan Sulowicz Wladyslaw Cockburn Elinor Reusch Michael Young James Dimkovic Nada B 
Info SWISS MEDICAL WEEKLY, (2021), vol. 151 br. , Suppl. 256, str. 7S-7S
Ispravka Web of Science   Elečas   Rang časopisa   Citati: Web of Science  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Roxadustat for the treatment of anemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, double-blind, placebo-controlled study (ALPS) (Article)
Autori Shutov Evgeny Sulowicz Wladyslaw Esposito Ciro Tataradze Avtandil Andric Branislav R Reusch Michael Valluri Udaya Dimkovic Nada B 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. 9, str. 1629-1639
Projekat Astellas Pharma, Inc.Astellas Pharmaceuticals
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
Naslov Roxadustat for the treatment of anaemia in chronic kidney disease patients not on dialysis: a Phase 3, randomized, open-label, active-controlled study (DOLOMITES) (Article)
Autori Barratt Jonathan Andric Branislav R Tataradze Avtandil Schoemig Michael Reusch Michael Valluri Udaya Mariat Christophe 
Info NEPHROLOGY DIALYSIS TRANSPLANTATION, (2021), vol. 36 br. 9, str. 1616-1628
Projekat Astellas Pharma, Inc.Astellas Pharmaceuticals
Ispravka Web of Science   Članak   Elečas   Rang časopisa   Citati: Web of Science   Scopus  
facebook sharing button
twitter sharing button
linkedin sharing button
gmail sharing button
copy sharing button
  • 1
  • 2
>> Sve godine

Ispis zapisa u formatu:TXT | BibTeX